Ron Martin, Distinguished Scientist and Fellow
Botanical Innovation and Strategy at Amway R&D, tells TechSci Research that
beyond treatments, another opportunity which is clearly emerging is
"prevention" of health conditions for which at least some patients
are genetically predisposed, and where changes in "environment"
(including diet) may forestall, or at least mitigate, the development of both
physical- and mental-health problems such as depression, anxiety, and
more.
TECHSCI RESEARCH- How is your work
related to Nutrigenomics?
EXPERT- I have completed my BS and MS degrees in Food Science and Nutrition
from Chapman University, in Orange, California.
I worked for more than 35 years in the dietary supplement and
food-related industries, mostly at Nutrilite (in Buena Park, California) where I
served as Senior Research Scientist in their Nutritional R&D and Product
Development departments.
While at
Nutrilite, I became fascinated with genetics in nutrition after attending both
the first and the second international conferences on nutritional genomics that
were held in 2002 and 2003 in the Netherlands, and organized by NuGO . After attending these conferences, it became
clear to me that differences in genetics might well explain why some people
respond favorably to dietary supplements, while some do not respond at all.
When I looked in the medical literature for more about nutritional genomics, I
found that inconsistent terminology makes it very difficult to find the
relevant research articles. For that
reason, I had made it my ongoing "mission" to make nutritional
genomics more readily accessible to anyone, and everyone, including to members
of the Public – which includes students, as well as educators.
With that aim in
mind, in early 2007 I founded the online database at Nutrigenetics.net -- which
is free for everyone to use on weekends (Pacific US time). In 2007 I also became one of the original
members of the International Society of Nutrigenetics & Nutrigenomics
(NutritionAndGenetics.org), and attended most of their past Congresses, most
recently their 15th Congress which was held in Monterrey, Mexico.
TECHSCI RESEARCH- As you mentioned,
you have founded a database can you please tell more about it?
EXPERT- The database at Nutrigenetics.net was originally aimed at
nutritional genomics, it became apparent that nutrition (and diet generally)
will overlap with many other genomics-related topics to one degree or
another. For that reason, the
Nutrigenetics.net database is continuously expanding in an ongoing effort to
include most of the omics-related PubMed articles that may be relevant to human
health, and it currently contains more than 2 million records that are also
present on PubMed. But unlike PubMed,
the Nutrigenetics.net database further indexes those article records with
standardized terminology (controlled vocabulary). This allows database users to create their
own customized lists of subtopics (indexes) for any given topic, or for any
given combination of topics, including for genes and genetic variants.
This ability of
database users to create their own customized subtopic listings (indexes) is
important because it allows users to clearly view (or even discover) many of
the otherwise hidden or obscured relationships, including which genes and
genetic variants are being discussed.
If someone
conducts a search on PubMed for nutrigenetics or nutrigenomics (per se), the
number of article records retrieved will be relatively small. However, if a wider net is cast for
omics-related articles in combination with articles which also mention any
diet-related words like curcumin, or resveratrol, etc., then the number of
PubMed records retrieved becomes impressive.
This is the approach that is used for the database at nutrigenetics.net,
which has identified nearly 170,000 PubMed records which are relevant to
nutrition or diet for the years 2000 to the present. The database at
Nutrigenetics.net does indeed contain a little over 250,000 PubMed articles
that are relevant to nutrition. However, only 170,000 of those 250,000 were
validated today as also referring to a gene or a genetics-related term (the
other 80,000 pertain to things like Alzheimer disease or Cardiovascular
Diseases or Neoplasms, but are more difficult to validate as being clearly
related to genetics or the various omics).
Moreover,
there's an important advantage to using "nutrition" as a catch-all
umbrella for all diet-related articles within the Nutrigenetics.net
database. The advantage is that when an
index of subtopics is created where "nutrition" is included as an
index or search topic, then essentially all of the more-specific diet-related
subtopics like curcumin, or resveratrol, etc., will appear in the subtopic
listings – which are otherwise easily overlooked, especially when a large
number of articles are involved.
By
systematically creating subtopics listings (first for one topic, then for
combinations of topics which are of interest to the user), these otherwise
easily-overlooked relationships become visible – including the genes and
genetic variants which are also mentioned within those same PubMed records.
We are no longer
living in a world where the old approach of "one size fits all" is
adequate, and this is why personalized healthcare (sometimes also called
"precision healthcare" or even "precision medicine") has
been emerging – and will continue to emerge.
TECHSCI RESEARCH- Can you elaborate
the use of nutrigenomics in the treatment or management of different diseases?
EXPERT- Yes, nutrigenomics is used in the treatment and management of
diseases but beyond treatments, another opportunity which is clearly emerging
is "prevention" of health conditions for which at least some patients
are genetically predisposed, and where changes in "environment"
(including diet) may forestall, or at least mitigate, the development of both
physical- and mental-health problems such as depression, anxiety, and
more.
TECHSCI RESEARCH- What forms an
integral part of nutrigenomics products such as vitamins & supplements,
probiotics, prebiotics, or nutrigenomics genetic testing?
EXPERT- Regarding commercialization of nutritional genomics, I am fully
persuaded that product like dietary supplements, including probiotics and
prebiotics, can play an important role, but it's a matter of what's appropriate
for the individual – which can be difficult for members of the public to
discern without the appropriate tools, and without cooperation with healthcare
professionals who are knowledgeable.
TECHSCI RESEARCH- How has the
scenario for nutrigenomics changed over the years? Has the demand increased or
decreased?
EXPERT- Over the years if I talk in terms of literature, earlier there was
a lack of information available related to nutrigenomics and now there is an overload
of information. So, both a lack of information and now some overload of
information helps explain the relatively slow uptake and
"translation" of the emerging information into practical healthcare
uses. And this slow uptake is further
complicated by "standards of practice" that apply to various health
services for the treatment of common health conditions. Clearly, more efforts are needed to build
consensus about adding more omics-related considerations to standard treatment
protocols.
After all, when
patients do not respond to a given standard of practice, then there is already
a growing opportunity (even duty) to look for better approaches that could
include more omics-related considerations.
Authors: Himanshu Saxena, Shaurya Singh
Please follow our LinkedIn and Twitter pages to get live updates on
market research insights and analysis.